EUVIMEDEUVIMED entdecken
Crossref

Neutrophil-Mediated Drug Delivery Nanoplatform Constructed from Celastrol Loaded Liposome for Targeted Therapy of Rheumatoid Arthritis

Yunshuang Jiao, Jicong Chen, Huijia Lei, Siyuan Hu, Yuanhao Yu, Jinsheng Yang, Yuyang Chen, Jie Yang iD, Lesheng Teng iD

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.5c05149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Yunshuang Jiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, P. R. China. Hauptthemen laut MEDLINE: Liposomes, Neutrophils, Arthritis, Rheumatoid, Triterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) may lead to irreversible joint damage, seriously affecting the health of patients. Cell-mediated drug delivery strategies provide a significant promise for improving drug delivery efficiency and enhancing therapeutic efficacy in RA. Herein, a neutrophil-mediated nanoplatform, constructed from celastrol-loaded liposome (LP-Cel) and neutrophils (NEs) on the outer surface capable of inflammation migration ability, namely, NEs-LP-Cel, is developed for RA treatment. By exploiting the inflammatory environment of RA and the inflammatory chemotaxis of neutrophils, LP-Cel is transported to inflamed tissues to release celastrol and display anti-inflammatory effects. Experimental results demonstrate that NEs-LP-Cel can effectively accumulate at the inflammation sites, reduce paw swelling, and decrease the expression of inflammatory factors (TNF-α and IL-1β) in joint tissues of RA rats, indicating enhanced therapeutic effects and negligible side effects, providing a new way for using neutrophil-mediated nanocarriers as delivery nanoplatforms to achieve treatment in inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesNeutrophilsArthritis, RheumatoidTriterpenesAnti-Inflammatory AgentsPentacyclic TriterpenesAnimalsRatsInterleukin-1betaDrug Delivery SystemsTumor Necrosis Factor-alphaHumansMaleRats, Sprague-Dawley

Stichwörter der Autor:innen

celastroldrug deliveryliposomesneutrophilsrheumatoid arthritis

Substanzen

Pentacyclic TriterpenescelastrolLiposomesTriterpenesInterleukin-1betaTumor Necrosis Factor-alphaAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, P. R. China.

ORCID-Profile: Jie Yang, Lesheng Teng

Förderung

  • Natural Science Foundation of Jilin Province
  • National Natural Science Foundation of China

Zitieren

APA

Jiao, Y., Chen, J., Lei, H., Hu, S., Yu, Y., Yang, J., Chen, Y., Yang, J., & Teng, L. (2026). Neutrophil-Mediated Drug Delivery Nanoplatform Constructed from Celastrol Loaded Liposome for Targeted Therapy of Rheumatoid Arthritis. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c05149

Vancouver

Jiao Y, Chen J, Lei H, Hu S, Yu Y, Yang J, et al. Neutrophil-Mediated Drug Delivery Nanoplatform Constructed from Celastrol Loaded Liposome for Targeted Therapy of Rheumatoid Arthritis. Nano Letters. 2026. doi:10.1021/acs.nanolett.5c05149

BibTeX
@article{Jiao2026,
  author = {Jiao, Yunshuang and Chen, Jicong and Lei, Huijia and Hu, Siyuan and Yu, Yuanhao and Yang, Jinsheng and Chen, Yuyang and Yang, Jie and Teng, Lesheng},
  title = {Neutrophil-Mediated Drug Delivery Nanoplatform Constructed from Celastrol Loaded Liposome for Targeted Therapy of Rheumatoid Arthritis},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.5c05149}
}
Kostenlos starten →